Verified ProfileEN

Panjin Huacheng Pharmaceutical Co.,Ltd.

Order verification — $199

Manufacturing · Traditional Chinese Medicine Decoction Pieces Processing

Verification dossier

Panjin Huacheng Pharmaceutical Co.,Ltd. is a Chinese company based in Panjin, Liaoning. The company operates in the traditional chinese medicine decoction pieces processing sector, within the broader manufacturing industry. Established 2004, the company has been operating for 22 years.

Sinolinks tracks Panjin Huacheng Pharmaceutical Co.,Ltd. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Production and operation of traditional Chinese medicine extracts, raw materials, and by-products of silymarin oil; export of self-produced products and related technology; import of raw and auxiliary materials, machinery, equipment, instruments, and related technology for R&D (excluding goods and technologies restricted or prohibited by the state); processing of imported materials and "three来一补" business; cultivation and sales of seedlings, flowers, and Chinese medicinal materials; import and export of goods, import and export of technology. (Subject to approval by relevant authorities).

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review